Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001493152-23-046131
Filing Date
2023-12-26
Accepted
2023-12-26 16:05:20
Documents
1
Effectiveness Date
2023-12-26
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 11363
  Complete submission text file 0001493152-23-046131.txt   12739
Mailing Address 3655 NOBEL DRIVE SUITE 260 SAN DIEGO CA 92122
Business Address 3655 NOBEL DRIVE SUITE 260 SAN DIEGO CA 92122 858-926-7655
Dare Bioscience, Inc. (Filer) CIK: 0001401914 (see all company filings)

EIN.: 204139823 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-500747 | Film No.: 231513358
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)